Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04902326 · ClinicalTrials.gov registry record · NA
Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change)
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 380
- Enrollment target
NCT04902326 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 380 participants.
The verdict
NCT04902326, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
Study Summary
Patients with prediabetes can significantly reduce their risk of developing type 2 diabetes mellitus (T2DM) by participating in a Diabetes Prevention Program (DPP) or using metformin, but very few patients with prediabetes engage in these strategies. This randomized controlled trial will compare, among adults with prediabetes, the effectiveness of financial incentives, tailored messages based on self-determination theory (SDT) principles, and the combination of financial incentives plus tailored messages based on SDT principles in decreasing hemoglobin A1c (HbA1c) and weight and in increasing participation in a DPP or use of metformin. Our main hypotheses are that the mean decrease in HbA1c will be greater in the arm that receives a combination of financial incentives plus tailored messages than in the arm that receives generic health education messages, and that the mean decrease in HbA1c will be greater in the arm that receives a combination of financial incentives plus tailored messages than in the arm that receives financial incentives alone and the arm that receives tailored messages alone. The study will also identify moderators and mediators of the effectiveness of the interventions and evaluate facilitators of and barriers to scalability, acceptability, and sustainability of the different interventions.
Interventions
- BEHAVIORAL Financial incentives
- BEHAVIORAL Automated educational text messages
- BEHAVIORAL Autonomy-supportive automated educational text messages
- BEHAVIORAL Tailored text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2021-09-16 |
| Est. Completion | 2023-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04902326
The ClinicalTrials.gov registry entry for NCT04902326 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Financial incentives is the first listed.
NCT04902326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04902326 about?
NCT04902326 is a clinical study titled "Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change)". Patients with prediabetes can significantly reduce their risk of developing type 2 diabetes mellitus (T2DM) by participating in a Diabetes Prevention Program (DPP) or using metformin, but very few patients with prediabetes engage in these strategies. This randomized controlled trial will compare, am...
What is the current status of trial NCT04902326?
This trial is currently completed. It is a NA study. The enrollment target is 380 participants. The study started on 2021-09-16. Estimated completion is 2023-09-18.
What interventions are being tested in trial NCT04902326?
The interventions under investigation include: Financial incentives (BEHAVIORAL), Automated educational text messages (BEHAVIORAL), Autonomy-supportive automated educational text messages (BEHAVIORAL), Tailored text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT04902326?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.